[1]
G. Gancitano, R. Ravasio, M. Dionisi, and D. Cortinovis, “Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer”, FE, vol. 19, no. 1, May 2018.